Health Scope

Published by: Kowsar
Corrected Proof scheduled for 7 (Special Issue of "Health Transformation Plan")

Consumer Instigated Unnecessary Medicalization in Iran: A Qualitative Thematic Analysis of the Health Professionals’ Conjectures

Abdolreza Shaghaghi 1 , 2 and Parinaz Doshmangir 1 , *
Authors Information
1 Health Education & Promotion Department, Faculty of Health , Tabriz University of Medical Sciences, Tabriz, Iran
2 Medical Education Research Center, R&D Campus, Tabriz University of Medical Sciences, Tabriz, Iran
Article information

To Cite: Shaghaghi A, Doshmangir P. Consumer Instigated Unnecessary Medicalization in Iran: A Qualitative Thematic Analysis of the Health Professionals’ Conjectures, Health Scope. Online ahead of Print ;In Press(In Press):e63062. doi: 10.5812/jhealthscope.63062.

Abstract
Copyright: Copyright © 2018, Journal of Health Scope. This is an open-access article distributed under the terms of the Creative Commons Attribution-NonCommercial 4.0 International License (http://creativecommons.org/licenses/by-nc/4.0/) which permits copy and redistribute the material just in noncommercial usages, provided the original work is properly cited.
1. Background
2. Objectives
3. Methods
4. Results
5. Discussion
References
  • 1. World Health Organization . Milestones in health promotion: Statements from global conferences. 2009. Available from: http://www.who.int/healthpromotion/Milestones_Health_Promotion_05022010.pdf.
  • 2. Arunima SK. Medicalization: A growing menance. Delhi Psychiatry J. 2012;15(2):255-9.
  • 3. Sholl J. The muddle of medicalization: pathologizing or medicalizing?. Theor Med Bioeth. 2017;38(4):265-78. doi: 10.1007/s11017-017-9414-z. [PubMed: 28674861].
  • 4. Clark J. Medicalization of global health 1: has the global health agenda become too medicalized?. Glob Health Action. 2014;7:23998. doi: 10.3402/gha.v7.23998. [PubMed: 24848659].
  • 5. Williams SJ, Coveney C, Gabe J. The concept of medicalisation reassessed: a response to Joan Busfield. Sociol Health Illn. 2017;39(5):775-80. doi: 10.1111/1467-9566.12576. [PubMed: 28425106].
  • 6. Kvaale EP, Haslam N, Gottdiener WH. The 'side effects' of medicalization: a meta-analytic review of how biogenetic explanations affect stigma. Clin Psychol Rev. 2013;33(6):782-94. doi: 10.1016/j.cpr.2013.06.002. [PubMed: 23831861].
  • 7. Morgan DJ, Brownlee S, Leppin AL, Kressin N, Dhruva SS, Levin L, et al. Setting a research agenda for medical overuse. BMJ. 2015;351:h4534. doi: 10.1136/bmj.h4534. [PubMed: 26306661].
  • 8. Berral A, Pira E, Romano C. [Overdiagnosis and defensive medicine in occupational medicine]. G Ital Med Lav Ergon. 2014;36(4):321-31. [PubMed: 25558728].
  • 9. Gabe J, Williams S, Martin P, Coveney C. Pharmaceuticals and society: power, promises and prospects. Soc Sci Med. 2015;131:193-8. doi: 10.1016/j.socscimed.2015.02.031. [PubMed: 25727500].
  • 10. Moynihan R, Doust J, Henry D. Preventing overdiagnosis: how to stop harming the healthy. BMJ. 2012;344. e3502. doi: 10.1136/bmj.e3502. [PubMed: 22645185].
  • 11. Conrad P, Mackie T, Mehrotra A. Estimating the costs of medicalization. Soc Sci Med. 2010;70(12):1943-7. doi: 10.1016/j.socscimed.2010.02.019. [PubMed: 20362382].
  • 12. Correia T. Revisiting medicalization: A critique of the assumptions of what counts as medical knowledge. Frontiers Soc. 2017;2. doi: 10.3389/fsoc.2017.00014.
  • 13. Hofmann B. Medicalization and overdiagnosis: different but alike. Med Health Care Philos. 2016;19(2):253-64. doi: 10.1007/s11019-016-9693-6. [PubMed: 26912187].
  • 14. Blasco-Fontecilla H. Medicalization, wish-fulfilling medicine, and disease mongering: toward a brave new world?. Rev Clin Esp (Barc). 2014;214(2):104-7. doi: 10.1016/j.rce.2013.08.012. [PubMed: 24772477].
  • 15. van Dijk W, Faber MJ, Tanke MA, Jeurissen PP, Westert GP. Medicalisation and Overdiagnosis: What Society Does to Medicine. Int J Health Policy Manag. 2016;5(11):619-22. doi: 10.15171/ijhpm.2016.121. [PubMed: 27801356].
  • 16. Naraghi M, Saberi H, Mirmohseni AS, Nikdad MS, Afarideh M. Management of advanced intracranial intradural juvenile nasopharyngeal angiofibroma: combined single-stage rhinosurgical and neurosurgical approach. Int Forum Allergy Rhinol. 2015;5(7):650-8. doi: 10.1002/alr.21507.
  • 17. Jamoulle M. Quaternary prevention, an answer of family doctors to overmedicalization. Int J Health Policy Manag. 2015;4(2):61-4. doi: 10.15171/ijhpm.2015.24. [PubMed: 25674569].
  • 18. Conrad P. The shifting engines of medicalization. J Health Soc Behav. 2005;46(1):3-14. doi: 10.1177/002214650504600102. [PubMed: 15869117].
  • 19. Merianos AL, Vidourek RA, King KK. Medicalization of female beauty: A content analysis of cosmetic procedures. Qual Rep. 2013;18(46):1-14.
  • 20. Mintzes B. For and against: Direct to consumer advertising is medicalising normal human experience: For. BMJ. 2002;324(7342):908-9. doi: 10.1136/bmj.324.7342.908. [PubMed: 11950745].
  • 21. Wyatt WJ. Behavior analysis in the era of medicalization: the state of the science and recommendations for practitioners. Behav Anal Pract. 2009;2(2):49-57. doi: 10.1007/BF03391748. [PubMed: 22477707].
  • 22. Dwarswaard J, Hilhorst M, Trappenburg M. The doctor and the market: about the influence of market reforms on the professional medical ethics of surgeons and general practitioners in the Netherlands. Health Care Anal. 2011;19(4):388-402. doi: 10.1007/s10728-011-0166-z. [PubMed: 21267659].
  • 23. Khalifeh MM, Moore ND, Salameh PR. Self-medication misuse in the Middle East: a systematic literature review. Pharmacol Res Perspect. 2017;5(4). doi: 10.1002/prp2.323. [PubMed: 28805984].
  • 24. Omani-Samani R, Mohammadi M, Almasi-Hashiani A, Maroufizadeh S. Cesarean Section and Socioeconomic Status in Tehran, Iran. J Res Health Sci. 2017;17(4). e00394. [PubMed: 29233956].
  • 25. Ferdosi M, Kabiri S, Keyvanara M, Yarmohammadian MH. Challenges of iran health transformation plan about inpatients payment: Viewpoint of experts. Health Scope. 2017;In Press(In Press). doi: 10.5812/jhealthscope.14388.
  • 26. Homaie Rad E, Yazdi-Feyzabad V, Yousefzadeh-Chabok S, Afkar A, Naghibzadeh A. Pros and cons of the health transformation program in Iran: evidence from financial outcomes at the household level. Epidemiol Health. 2017;39. e2017029. doi: 10.4178/epih.e2017029. [PubMed: 28728347].
  • 27. Noble H, Smith J. Issues of validity and reliability in qualitative research. Evid Based Nurs. 2015;18(2):34-5. doi: 10.1136/eb-2015-102054. [PubMed: 25653237].
  • 28. Carter SM. Overdiagnosis: An Important Issue That Demands Rigour and Precision Comment on "Medicalisation and Overdiagnosis: What Society Does to Medicine". Int J Health Policy Manag. 2017;6(10):611-3. doi: 10.15171/ijhpm.2017.24. [PubMed: 28949478].
  • 29. Vian T. Review of corruption in the health sector: theory, methods and interventions. Health Policy Plan. 2008;23(2):83-94. doi: 10.1093/heapol/czm048. [PubMed: 18281310].
  • 30. Lantz PM, Lichtenstein RL, Pollack HA. Health policy approaches to population health: the limits of medicalization. Health Aff (Millwood). 2007;26(5):1253-7. doi: 10.1377/hlthaff.26.5.1253. [PubMed: 17848434].
  • 31. McQueen DV, De Salazar L. Health promotion, the Ottawa Charter and 'developing personal skills': a compact history of 25 years. Health Promot Int. 2011;26 Suppl 2:ii194-201. doi: 10.1093/heapro/dar063. [PubMed: 22080074].
Creative Commons License Except where otherwise noted, this work is licensed under Creative Commons Attribution Non Commercial 4.0 International License .

Search Relations:

Author(s):

Article(s):

Create Citiation Alert
via Google Reader